London Guidry, MD
Vascular Surgery · Baton Rouge, LANPI 1841461514
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 59.9% of the total. Reporting peaked in 2019 at $13,658 and has fallen 91.2% since, to $1,206 in 2025.
Across 207 payments — averaging $119.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- W. L. Gore & Associates, Inc.$2K
- Endologix LLC$2K
- Bard Peripheral Vascular, Inc.$1K
- Inari Medical, Inc.$788
- Penumbra, Inc.$742
- plus $4K from 23 others
What the payments were for
- Consulting fees$3,90016%
- Speaking & faculty fees$6,82528%
- Travel & lodging$3,62315%
- Food & beverage$10,31042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 41 | $14,778 |
| W. L. Gore & Associates, Inc. | 22 | $1,877 |
| Endologix LLC | 3 | $1,557 |
| Bard Peripheral Vascular, Inc. | 25 | $1,412 |
| Inari Medical, Inc. | 9 | $788 |
| Penumbra, Inc. | 10 | $742 |
| Shockwave Medical, Inc | 6 | $487 |
| Boston Scientific | 15 | $376 |
| Silk Road Medical, Inc. | 3 | $366 |
| Cook Medical LLC | 6 | $356 |
| Kerecis Limited | 10 | $314 |
| Johnson & Johnson(2 entities) | 11 | $246 |
| Smith+Nephew | 13 | $200 |
| Avinger Inc. | 3 | $192 |
| Cardiovascular Systems Inc. | 2 | $180 |
| Tactile Systems Technology Inc | 6 | $149 |
| Fresenius USA Marketing, Inc. | 6 | $133 |
| Terumo Medical Corporation | 1 | $128 |
| Surmodics, Inc. | 1 | $94 |
| Angiodynamics, Inc. | 2 | $88 |
| EKOS Corporation | 4 | $52 |
| Laminate Medical Technologies Inc. | 1 | $23 |
| Lemaitre Vascular, Inc. | 1 | $22 |
| Argon Medical Devices, Inc. | 1 | $21 |
| Bolton Medical Inc | 1 | $21 |
| Abbott | 1 | $15 |
| Pfizer | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$10,973
- IN.PACT AV$2,925
- Alto Abdominal Stent Graft System$920
- GORE VIABAHN VBX Balloon Expandable Endo$734
- FLOWTRIEVER CATHETER, S$596
- ENROUTE Transcarotid Neuroprotection System$448
- CT THROMBECTOMY SYSTEM KIT$352
- Ovation$327
- AFX2$327
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$323
- ENDOCROSS Device$311
- Torus Stent Graft System$311
- ENROUTE Transcarotid Stent$282
- Cook Medical Zilver PTX$241
- GORE VIABAHN Endoprosthesis with Heparin$199
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$165
- Indigo System$146
- Penumbra System$146
- GORE TAG Conformable Thoracic Endoprosthesis$142
- VIABAHN VBX Balloon Expandable Endoprosthesis$130
How this compares
$24,658 in reported general payments places this provider in the 85th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 94 | $64,385 |
| EliquisApixaban | 38 | $24,835 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 74 | $1,073 |
| Gabapentin | 62 | $982 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $316 |
| ClopidogrelClopidogrel Bisulfate | 31 | $236 |
| Pregabalin | 24 | $206 |
| Cilostazol | 15 | $144 |
| Alprazolam | 14 | $132 |
| Tramadol Hcl | 16 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $76 |
| Mupirocin | 12 | $71 |
| Ropinirole Hcl | 14 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $246 | $64,38594 claims |
| PfizerEliquis | $14 | $24,83538 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 65 vascular surgery providers in Louisiana.
Other vascular surgery in Baton Rouge
- Michael Conners IiiBaton Rouge$70K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- Paul DavisBaton Rouge$18K
- Gulrez MahmoodBaton Rouge$9K
- Matthew AbateBaton Rouge$9K
- Wajeeh IrfanBaton Rouge$7K
- Taylor GwinBaton Rouge$7K
- Madeline DillsBaton Rouge$5K
- James McNeilBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.